Hananeh Baradaran
1 
, Hadi Hamishehkar
2, Haleh Rezaee
2* 1 Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2 Department of Clinical Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient
evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients’ symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy.